Target intelligence / Profile preview

Killer cell lectin-like receptor K1 (NKG2D) (NKG2D)

Target
NKG2D
Molecular classification
Receptor, C-type lectin receptor
01

Overview

The Killer cell lectin-like receptor K1, commonly known as NKG2D, is a type II transmembrane protein belonging to the NKG2 family of C-type lectin-like receptors, encoded by the KLRK1 gene on chromosome 12p13.2. It functions as an activating and costimulatory receptor primarily expressed on natural killer (NK) cells, CD8+ T cells, and γδ T cells, where it recognizes stress-inducible ligands such as MICA, MICB, and ULBPs on the surface of virus-infected, transformed, or stressed cells. Upon ligand binding, NKG2D associates with the adaptor protein DAP10/DAP12, triggering signaling cascades that promote calcium influx, cytokine production (e.g., TNF-alpha), and perforin-mediated cytotoxicity, thereby enabling immunosurveillance against tumors and pathogens. In adaptive immunity, it amplifies T-cell receptor signaling in CD8+ T cells. Dysregulation of NKG2D expression or polymorphisms in KLRK1 are linked to altered NK cell activity, increased cancer risk, autoimmune disorders like celiac disease, and susceptibility to infections such as cowpox. Although no approved drugs directly target NKG2D, its role in recognizing stressed cells positions it as a promising therapeutic target for enhancing anti-tumor immunity or modulating immune responses in cancer and infectious diseases.

Other names
NKG2DKiller cell lectin-like receptor subfamily K member 1
02

Mechanism of action

null

03

Biological functions

Immune responseSignal transductionImmunosurveillanceCytotoxic activity
04

Disease associations

CancerInfectionAutoimmune diseaseCeliac diseaseCowpox
05

Safety considerations

Potential for excessive immune activation leading to autoimmunity or transplant rejection

Beyond the preview

Go deeper on Killer cell lectin-like receptor K1 (NKG2D) (NKG2D).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Killer cell lectin-like receptor K1 (NKG2D) (NKG2D).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call